Skip Navigation
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Your Environment. Your Health.

Publication Detail

Title: Effect of arsenic on transcription factor AP-1 and NF-kappaB DNA binding activity and related gene expression.

Authors: Hu, Yu; Jin, Ximei; Snow, Elizabeth T

Published In Toxicol Lett, (2002 Jul 07)

Abstract: Both acute (24 h) and chronic (10-20 week) exposure of human fibroblast cells to low dose sodium arsenite (As(III)) significantly affects activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) DNA binding activity. Short-term treatment with 0.1-5 microM As(III) up-regulates expression of c-Fos and c-Jun and the redox regulators, thioredoxin (Trx) and Redox factor-1 (Ref-1) and activates both AP-1 and NF-kappa B binding. Chronic exposure to 0.1 or 0.5 microM As(III) decreased c-Jun, c-Fos and Ref-1 protein levels and AP-1 and NF-kappa B binding activity, but increased Trx expression. Short term exposure to phorbol 12-myristate 13-acetate (TPA), a phorbol ester tumour promoter, or hydrogen peroxide (H(2)O(2)) also activates AP-1 and NF-kappa B binding. However, pre-treatment with As(III) prevents this increase. These results suggest that As(III) may alter AP-1 and NF-kappa B activity, in part, by up-regulating Trx and Ref-1. The different effects of short- versus long-term As(III) treatment on acute-phase response to oxidative stress reflect changes in the expression of Ref-1, c-Fos and c-Jun, but not Trx.

PubMed ID: 12076508 Exiting the NIEHS site

MeSH Terms: Arsenites/toxicity*; Cells, Cultured; DNA/drug effects*; DNA/metabolism; Dose-Response Relationship, Drug; Enzyme Inhibitors/toxicity*; Fibroblasts/drug effects; Fibroblasts/metabolism; Gene Expression Regulation/drug effects*; Humans; NF-kappa B/drug effects*; NF-kappa B/metabolism; Reverse Transcriptase Polymerase Chain Reaction; Sodium Compounds/toxicity*; Transcription Factor AP-1/drug effects*; Transcription Factor AP-1/metabolism

to Top